In preclinical studies, IL-6 has been demonstrated to promote breast cancer cell migration in cooperation with EGFR signaling, through an autocrine loop involving EGF family ligands that contribute with IL-6 in inducing ERK activation [14]. The gene discussed is IL6; the disease is breast carcinoma.